ONJ Cancer Research Institute
@onjcri.org.au
We are an independent research institute focused on translational research into more effective, tolerable and accessible cancer treatments for all.
Significant new results from ONJCRI’s Phase II rare cancer clinical trial on combination immunotherapy in dMMR/MSI-H non-colorectal cancers have been published in @jamaoncology.com.
➡️ Learn more: jamanetwork.com/journals/jam...
#RareCancers #RareCancerTrial #ClinicalTrials #ONJCRI
➡️ Learn more: jamanetwork.com/journals/jam...
#RareCancers #RareCancerTrial #ClinicalTrials #ONJCRI
November 14, 2025 at 2:14 AM
Significant new results from ONJCRI’s Phase II rare cancer clinical trial on combination immunotherapy in dMMR/MSI-H non-colorectal cancers have been published in @jamaoncology.com.
➡️ Learn more: jamanetwork.com/journals/jam...
#RareCancers #RareCancerTrial #ClinicalTrials #ONJCRI
➡️ Learn more: jamanetwork.com/journals/jam...
#RareCancers #RareCancerTrial #ClinicalTrials #ONJCRI
ONJCRI researchers have found that differentiation grade does not change significantly following cancer spread, suggesting that studying the primary tumour alone will be sufficient to understand the metastasis in most cases.
➡️ Full paper: https://ow.ly/SK0T50XmUct
#ColorectalCancer #CancerResearch
➡️ Full paper: https://ow.ly/SK0T50XmUct
#ColorectalCancer #CancerResearch
November 6, 2025 at 12:00 AM
ONJCRI researchers have found that differentiation grade does not change significantly following cancer spread, suggesting that studying the primary tumour alone will be sufficient to understand the metastasis in most cases.
➡️ Full paper: https://ow.ly/SK0T50XmUct
#ColorectalCancer #CancerResearch
➡️ Full paper: https://ow.ly/SK0T50XmUct
#ColorectalCancer #CancerResearch
ONJCRI was delighted to host our third Science Meets Art exhibition, welcoming members of the community, patient advocates and our supporters.
A huge thank you to the North East Community Fund, the artists and the dedicated Committee who made this event come to life!
➡️ https://ow.ly/YGyK50XmSni
A huge thank you to the North East Community Fund, the artists and the dedicated Committee who made this event come to life!
➡️ https://ow.ly/YGyK50XmSni
November 5, 2025 at 4:00 AM
ONJCRI was delighted to host our third Science Meets Art exhibition, welcoming members of the community, patient advocates and our supporters.
A huge thank you to the North East Community Fund, the artists and the dedicated Committee who made this event come to life!
➡️ https://ow.ly/YGyK50XmSni
A huge thank you to the North East Community Fund, the artists and the dedicated Committee who made this event come to life!
➡️ https://ow.ly/YGyK50XmSni
ONJCRI joins AAMRI in calling on the Federal Government to release the full MRFF in the 26–27 Federal Budget.
The MRFF was created to deliver $1 billion every year for lifesaving research, but currently, only about $650 million is being released.
Visit aamri.org.au/mrff/
#releasethefullMRFF
The MRFF was created to deliver $1 billion every year for lifesaving research, but currently, only about $650 million is being released.
Visit aamri.org.au/mrff/
#releasethefullMRFF
November 2, 2025 at 10:28 PM
ONJCRI joins AAMRI in calling on the Federal Government to release the full MRFF in the 26–27 Federal Budget.
The MRFF was created to deliver $1 billion every year for lifesaving research, but currently, only about $650 million is being released.
Visit aamri.org.au/mrff/
#releasethefullMRFF
The MRFF was created to deliver $1 billion every year for lifesaving research, but currently, only about $650 million is being released.
Visit aamri.org.au/mrff/
#releasethefullMRFF
Reposted by ONJ Cancer Research Institute
Our fantastic @onjcri.org.au and @lardr.bsky.social teams presenting lymphoma research orals at #HSANZ Blood conference in Perth. Dr Liz Goodall, Dr Allison barraclough, Eliza Chung and Rebecca nightingale and Dr Arina Martynchyk. All rising @womeninlymphoma.bsky.social
October 30, 2025 at 12:00 PM
Our fantastic @onjcri.org.au and @lardr.bsky.social teams presenting lymphoma research orals at #HSANZ Blood conference in Perth. Dr Liz Goodall, Dr Allison barraclough, Eliza Chung and Rebecca nightingale and Dr Arina Martynchyk. All rising @womeninlymphoma.bsky.social
New trial sites have been activated for the advanced #cholangiocarcinoma BIL-PPP phase II study in VIC, NSW, QLD and SA, making it accessible to more Australians.
➡️ Learn more: https://ow.ly/xqo650XjsBM
The BIL-PPP trial is funded by the Wayne Elphinstone Memorial Fund, AstraZeneca and AGITG
➡️ Learn more: https://ow.ly/xqo650XjsBM
The BIL-PPP trial is funded by the Wayne Elphinstone Memorial Fund, AstraZeneca and AGITG
October 29, 2025 at 4:00 AM
New trial sites have been activated for the advanced #cholangiocarcinoma BIL-PPP phase II study in VIC, NSW, QLD and SA, making it accessible to more Australians.
➡️ Learn more: https://ow.ly/xqo650XjsBM
The BIL-PPP trial is funded by the Wayne Elphinstone Memorial Fund, AstraZeneca and AGITG
➡️ Learn more: https://ow.ly/xqo650XjsBM
The BIL-PPP trial is funded by the Wayne Elphinstone Memorial Fund, AstraZeneca and AGITG
Catch ONJCRI’s Dr Pavitha Parathan and Dr @davidyiju.bsky.social on @drshanerrr.bsky.social’s RRR program, Einstein A Go-Go this morning 📻
Talking bowel cancer and novel cancer treatment delivery systems 🔬
#sciencemedia #cancerresearch
Talking bowel cancer and novel cancer treatment delivery systems 🔬
#sciencemedia #cancerresearch
October 26, 2025 at 12:25 AM
Catch ONJCRI’s Dr Pavitha Parathan and Dr @davidyiju.bsky.social on @drshanerrr.bsky.social’s RRR program, Einstein A Go-Go this morning 📻
Talking bowel cancer and novel cancer treatment delivery systems 🔬
#sciencemedia #cancerresearch
Talking bowel cancer and novel cancer treatment delivery systems 🔬
#sciencemedia #cancerresearch
ONJCRI researchers have linked two nervous system components to bowel cancer growth, creating promising new avenues for treatment with existing approved migraine therapies.
The findings were published in The BMJ Oncology today.
➡️ https://ow.ly/PCFE50XfWVh
#BowelCancer #Neuropeptides #ONJCRI
The findings were published in The BMJ Oncology today.
➡️ https://ow.ly/PCFE50XfWVh
#BowelCancer #Neuropeptides #ONJCRI
October 24, 2025 at 6:30 AM
ONJCRI researchers have linked two nervous system components to bowel cancer growth, creating promising new avenues for treatment with existing approved migraine therapies.
The findings were published in The BMJ Oncology today.
➡️ https://ow.ly/PCFE50XfWVh
#BowelCancer #Neuropeptides #ONJCRI
The findings were published in The BMJ Oncology today.
➡️ https://ow.ly/PCFE50XfWVh
#BowelCancer #Neuropeptides #ONJCRI
We are thrilled to be partners with the @cccolab.bsky.social and are looking forward to working together to improve outcomes for children with cancer.
We welcome Olivia Newton-John Cancer Research Institute as Children's Cancer CoLab’s 9th research partner:
www.cccolab.org.au/news-stories...
@onjcri.org.au @hudsonresearch.bsky.social @petermaccc.bsky.social @wehi-research.bsky.social @monashuniversity.bsky.social
#ChildhoodCancer #Leukaemia
www.cccolab.org.au/news-stories...
@onjcri.org.au @hudsonresearch.bsky.social @petermaccc.bsky.social @wehi-research.bsky.social @monashuniversity.bsky.social
#ChildhoodCancer #Leukaemia
October 23, 2025 at 1:00 AM
We are thrilled to be partners with the @cccolab.bsky.social and are looking forward to working together to improve outcomes for children with cancer.
This National Carers Week, we celebrate the significant role of carers in the lives of people with cancer by sharing the powerful story of one of ONJCRI’s valued supporters.
➡️ Read Gary's story: https://ow.ly/JZQV50XaRtu
➡️ Read Gary's story: https://ow.ly/JZQV50XaRtu
October 16, 2025 at 12:00 AM
This National Carers Week, we celebrate the significant role of carers in the lives of people with cancer by sharing the powerful story of one of ONJCRI’s valued supporters.
➡️ Read Gary's story: https://ow.ly/JZQV50XaRtu
➡️ Read Gary's story: https://ow.ly/JZQV50XaRtu
ONJCRI researchers and collaborators at @unimelb.bsky.social and RMIT have developed a novel nanomedicine delivery system with highly ordered structures that enhance cargo delivery to their targets.
➡️ Read the paper: ow.ly/XmYX50X1j4I
#LipidNanoparticles #Nanomedicine #CancerResearch
➡️ Read the paper: ow.ly/XmYX50X1j4I
#LipidNanoparticles #Nanomedicine #CancerResearch
September 25, 2025 at 5:00 AM
ONJCRI researchers and collaborators at @unimelb.bsky.social and RMIT have developed a novel nanomedicine delivery system with highly ordered structures that enhance cargo delivery to their targets.
➡️ Read the paper: ow.ly/XmYX50X1j4I
#LipidNanoparticles #Nanomedicine #CancerResearch
➡️ Read the paper: ow.ly/XmYX50X1j4I
#LipidNanoparticles #Nanomedicine #CancerResearch
Today, we celebrate World Cancer Research Day, a recognition of the vital role of research in improving cancer outcomes and reducing the global cancer burden.
➡️ Learn more about our research: www.onjcri.org.au/ou...
#WorldCancerResearchDay
➡️ Learn more about our research: www.onjcri.org.au/ou...
#WorldCancerResearchDay
September 24, 2025 at 12:00 AM
Today, we celebrate World Cancer Research Day, a recognition of the vital role of research in improving cancer outcomes and reducing the global cancer burden.
➡️ Learn more about our research: www.onjcri.org.au/ou...
#WorldCancerResearchDay
➡️ Learn more about our research: www.onjcri.org.au/ou...
#WorldCancerResearchDay
Reposted by ONJ Cancer Research Institute
We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.
September 12, 2025 at 12:04 AM
We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.
Researchers at ONJCRI, the University of Washington and @wehi-research.bsky.social have created novel "designer proteins" that can both activate and block cell death as required under different conditions.
➡️ Read the Science Advances paper: ow.ly/5glk50WSRnT
#CellDeath #Apoptosis #ONJCRI
➡️ Read the Science Advances paper: ow.ly/5glk50WSRnT
#CellDeath #Apoptosis #ONJCRI
September 8, 2025 at 6:00 AM
Researchers at ONJCRI, the University of Washington and @wehi-research.bsky.social have created novel "designer proteins" that can both activate and block cell death as required under different conditions.
➡️ Read the Science Advances paper: ow.ly/5glk50WSRnT
#CellDeath #Apoptosis #ONJCRI
➡️ Read the Science Advances paper: ow.ly/5glk50WSRnT
#CellDeath #Apoptosis #ONJCRI
Researchers at ONJCRI, @wehi-research.bsky.social and @petermaccc.bsky.social have discovered that a known protein complex can stop a common type of blood cancer in its tracks.
The findings were published in @natcomms.nature.com
➡️ Read more: ow.ly/Ca4S50WHVrA
#Lymphoma #CRISPR
The findings were published in @natcomms.nature.com
➡️ Read more: ow.ly/Ca4S50WHVrA
#Lymphoma #CRISPR
August 22, 2025 at 1:00 AM
Researchers at ONJCRI, @wehi-research.bsky.social and @petermaccc.bsky.social have discovered that a known protein complex can stop a common type of blood cancer in its tracks.
The findings were published in @natcomms.nature.com
➡️ Read more: ow.ly/Ca4S50WHVrA
#Lymphoma #CRISPR
The findings were published in @natcomms.nature.com
➡️ Read more: ow.ly/Ca4S50WHVrA
#Lymphoma #CRISPR
📚 Congratulations to Dr Sarah Yeo, lead author of TRACKER Biobank's first peer-reviewed publication, which explores the challenges and future directions for lung cancer biobanking in Australia.
Read the review here: ow.ly/jlvA50Wze5Y
#LungCancerResearch #CancerResearch #Biobank #ONJCRI
Read the review here: ow.ly/jlvA50Wze5Y
#LungCancerResearch #CancerResearch #Biobank #ONJCRI
August 5, 2025 at 4:00 AM
📚 Congratulations to Dr Sarah Yeo, lead author of TRACKER Biobank's first peer-reviewed publication, which explores the challenges and future directions for lung cancer biobanking in Australia.
Read the review here: ow.ly/jlvA50Wze5Y
#LungCancerResearch #CancerResearch #Biobank #ONJCRI
Read the review here: ow.ly/jlvA50Wze5Y
#LungCancerResearch #CancerResearch #Biobank #ONJCRI
Reposted by ONJ Cancer Research Institute
Today, we stand with patients, families, clinicians, and researchers to raise awareness of lung cancer.
- 36 Australians are diagnosed with lung cancer each day
- Lung cancer claims the most lives of any cancer in Australia
- Less than 6% of cancer research funding is allocated to thoracic cancers
- 36 Australians are diagnosed with lung cancer each day
- Lung cancer claims the most lives of any cancer in Australia
- Less than 6% of cancer research funding is allocated to thoracic cancers
July 31, 2025 at 11:01 PM
Today, we stand with patients, families, clinicians, and researchers to raise awareness of lung cancer.
- 36 Australians are diagnosed with lung cancer each day
- Lung cancer claims the most lives of any cancer in Australia
- Less than 6% of cancer research funding is allocated to thoracic cancers
- 36 Australians are diagnosed with lung cancer each day
- Lung cancer claims the most lives of any cancer in Australia
- Less than 6% of cancer research funding is allocated to thoracic cancers
Reposted by ONJ Cancer Research Institute
Bowel cancer rates are rising in young people, and researchers are working tirelessly to find out why, writes Dr Lisa Mielke
buff.ly/SpTGiBQ
@onjcri.org.au @lisa-mielke.bsky.social
buff.ly/SpTGiBQ
@onjcri.org.au @lisa-mielke.bsky.social
July 27, 2025 at 2:00 AM
Bowel cancer rates are rising in young people, and researchers are working tirelessly to find out why, writes Dr Lisa Mielke
buff.ly/SpTGiBQ
@onjcri.org.au @lisa-mielke.bsky.social
buff.ly/SpTGiBQ
@onjcri.org.au @lisa-mielke.bsky.social
🎗️ This World Head and Neck Cancer Day, we're highlighting ONJCRI's START-HN trial: a game-changing combination of precision radiotherapy and revolutionary immune monitoring techniques that can track how immune cells respond to treatment.
Read more here: ow.ly/el1V50WvBBy
Read more here: ow.ly/el1V50WvBBy
July 27, 2025 at 12:00 AM
🎗️ This World Head and Neck Cancer Day, we're highlighting ONJCRI's START-HN trial: a game-changing combination of precision radiotherapy and revolutionary immune monitoring techniques that can track how immune cells respond to treatment.
Read more here: ow.ly/el1V50WvBBy
Read more here: ow.ly/el1V50WvBBy
We are thrilled to share that the ACRF Centre for Precision Medicine has officially opened at ONJCRI.
Thank you to ACRF for making this new facility become a reality.
➡️ Read more about our new Centre: ow.ly/mcJl50WtK57
#ACRF #CancerResearch #PrecisionMedicine #ONJCRI
Thank you to ACRF for making this new facility become a reality.
➡️ Read more about our new Centre: ow.ly/mcJl50WtK57
#ACRF #CancerResearch #PrecisionMedicine #ONJCRI
July 23, 2025 at 6:00 AM
We are thrilled to share that the ACRF Centre for Precision Medicine has officially opened at ONJCRI.
Thank you to ACRF for making this new facility become a reality.
➡️ Read more about our new Centre: ow.ly/mcJl50WtK57
#ACRF #CancerResearch #PrecisionMedicine #ONJCRI
Thank you to ACRF for making this new facility become a reality.
➡️ Read more about our new Centre: ow.ly/mcJl50WtK57
#ACRF #CancerResearch #PrecisionMedicine #ONJCRI
💡 Breakthrough in rare cancer care
Research led by Prof Eliza Hawkes shows that 3D imaging can revolutionise how we monitor treatment for primary central nervous system lymphoma (PCNSL), a rare but aggressive cancer.
Read the full study here: ow.ly/Nler50WqYMI
Research led by Prof Eliza Hawkes shows that 3D imaging can revolutionise how we monitor treatment for primary central nervous system lymphoma (PCNSL), a rare but aggressive cancer.
Read the full study here: ow.ly/Nler50WqYMI
July 17, 2025 at 6:00 AM
💡 Breakthrough in rare cancer care
Research led by Prof Eliza Hawkes shows that 3D imaging can revolutionise how we monitor treatment for primary central nervous system lymphoma (PCNSL), a rare but aggressive cancer.
Read the full study here: ow.ly/Nler50WqYMI
Research led by Prof Eliza Hawkes shows that 3D imaging can revolutionise how we monitor treatment for primary central nervous system lymphoma (PCNSL), a rare but aggressive cancer.
Read the full study here: ow.ly/Nler50WqYMI
🧠 This Glioblastoma (GBM) Awareness Day, we highlight The Centre for Research Excellence in Brain Cancer's Biomarkers in Brain project.
"This valuable resource will allow us to push forward with research to find better treatments for GBM patients.”
➡️ Learn more: ow.ly/NFAm50Wqiel
"This valuable resource will allow us to push forward with research to find better treatments for GBM patients.”
➡️ Learn more: ow.ly/NFAm50Wqiel
July 16, 2025 at 2:00 AM
🧠 This Glioblastoma (GBM) Awareness Day, we highlight The Centre for Research Excellence in Brain Cancer's Biomarkers in Brain project.
"This valuable resource will allow us to push forward with research to find better treatments for GBM patients.”
➡️ Learn more: ow.ly/NFAm50Wqiel
"This valuable resource will allow us to push forward with research to find better treatments for GBM patients.”
➡️ Learn more: ow.ly/NFAm50Wqiel
Congratulations to Dr Lisa Mielke, who received a prestigious Australian Research Council (ARC) Future Fellowship totalling $1.13 million to research new molecules for future drug and vaccine development.
➡️ Learn more: ow.ly/GSAP50Wo6L1
#FutureFellowship #ONJCRI
➡️ Learn more: ow.ly/GSAP50Wo6L1
#FutureFellowship #ONJCRI
Dr Lisa Mielke awarded ARC Future Fellowship
This ARC Future Fellowship will allow Dr Mielke and her team to research new molecules for future drug and vaccine development.
ow.ly
July 11, 2025 at 6:00 AM
Congratulations to Dr Lisa Mielke, who received a prestigious Australian Research Council (ARC) Future Fellowship totalling $1.13 million to research new molecules for future drug and vaccine development.
➡️ Learn more: ow.ly/GSAP50Wo6L1
#FutureFellowship #ONJCRI
➡️ Learn more: ow.ly/GSAP50Wo6L1
#FutureFellowship #ONJCRI
🎯 Game-changer for lymphoma treatment
ONJCRI researchers have cracked the code on predicting which blood cancer patients will respond best to a powerful combo of radiotherapy and immunotherapy. In @bloodjournals.hematology.org
Read more on our website: ow.ly/CnZc50Wo6gw
#Cancer #Lymphoma
ONJCRI researchers have cracked the code on predicting which blood cancer patients will respond best to a powerful combo of radiotherapy and immunotherapy. In @bloodjournals.hematology.org
Read more on our website: ow.ly/CnZc50Wo6gw
#Cancer #Lymphoma
July 11, 2025 at 4:00 AM
🎯 Game-changer for lymphoma treatment
ONJCRI researchers have cracked the code on predicting which blood cancer patients will respond best to a powerful combo of radiotherapy and immunotherapy. In @bloodjournals.hematology.org
Read more on our website: ow.ly/CnZc50Wo6gw
#Cancer #Lymphoma
ONJCRI researchers have cracked the code on predicting which blood cancer patients will respond best to a powerful combo of radiotherapy and immunotherapy. In @bloodjournals.hematology.org
Read more on our website: ow.ly/CnZc50Wo6gw
#Cancer #Lymphoma
The first publication from our rare cancers clinical trial (MoST CIRCUIT) was published in @jamaoncology.com. Congratulations to A/Prof Oliver Klein and team!
Read more: ow.ly/gr8O50Wnnxv
Thank you to @bms-news.bsky.social, Omico, and the Minderoo Foundation.
Read more: ow.ly/gr8O50Wnnxv
Thank you to @bms-news.bsky.social, Omico, and the Minderoo Foundation.
Rare cancers clinical trial findings published in JAMA Oncology
This is the first publication on a patient cohort treated as part of the MoST CIRCUIT rare cancers clinical trial, sponsored by ONJCRI.
ow.ly
July 10, 2025 at 11:00 PM
The first publication from our rare cancers clinical trial (MoST CIRCUIT) was published in @jamaoncology.com. Congratulations to A/Prof Oliver Klein and team!
Read more: ow.ly/gr8O50Wnnxv
Thank you to @bms-news.bsky.social, Omico, and the Minderoo Foundation.
Read more: ow.ly/gr8O50Wnnxv
Thank you to @bms-news.bsky.social, Omico, and the Minderoo Foundation.